secret
glycosyl
polypeptid
contain
amino
acid
sar
coronaviru
sarscov
spike
protein
polyhistidin
tag
express
recombin
baculovirusinfect
insect
cell
mice
receiv
affinitypurifi
protein
either
saponin
ribi
mpl
tdm
adjuv
subcutan
challeng
intranas
sarscov
regimen
induc
bind
neutral
antibodi
protect
sarscov
intranas
infect
howev
best
result
obtain
protein
provid
highest
antibodi
well
complet
protect
upper
lower
respiratori
tract
publish
elsevi
inc
identif
etiolog
agent
sever
acut
respiratori
syndrom
sar
made
possibl
work
toward
develop
vaccin
therapeut
could
prevent
futur
recurr
diseas
sarscoronaviru
sarscov
nearli
nucleotid
long
rna
genom
open
read
frame
encod
four
major
structur
protein
consist
nucleocapsid
spike
membran
small
envelop
protein
marra
et
al
rota
et
al
protein
sarscov
typei
transmembran
glycoprotein
amino
acid
ident
correspond
protein
cov
unlik
cleav
subunit
sarscov
protein
mediat
cell
entri
bind
cell
receptor
identifi
angiotensinconvert
enzym
addit
sarscov
receptor
also
bind
recent
identifi
jeffer
et
al
target
neutral
antibodi
et
al
sui
et
al
make
import
candid
vaccin
applic
current
studi
vaccin
candid
protect
demonstr
anim
model
includ
dna
yang
et
al
modifi
vaccinia
viru
ankara
mva
bisht
et
al
parainfluenza
viru
type
vector
express
although
recombin
dna
express
vector
gener
induc
good
cell
mediat
immun
frequent
induc
high
antibodi
respons
adjuv
protein
demonstr
induct
neutral
antibodi
protect
immun
sarscov
infect
mice
induc
solubl
secret
polypeptid
contain
amino
acid
protein
combin
saponin
ribi
adjuv
mpl
tdm
compos
monophosphoryl
lipid
trehalos
dicorynomycol
adjuv
type
test
phase
clinic
trial
candid
vaccin
cancer
infecti
diseas
consid
impract
isol
natur
membranebound
glycoprotein
sarscov
instead
use
baculovirusinsect
cell
system
express
ntermin
fragment
ns
secret
glycosyl
protein
could
readili
purifi
nativ
condit
ntermin
amino
acid
protein
select
basi
hydrophil
secondari
structur
predict
use
kyte
dolittl
chou
fasman
algorithm
mcvector
includ
region
correspond
coronavirus
transfer
vector
construct
polyhedrin
promot
regul
express
protein
compris
amino
acid
preced
honeybe
melittin
signal
peptid
follow
six
histidin
fig
baculoviru
express
ns
deriv
recombin
insect
cell
yield
secret
affin
purifi
ns
approxim
mgl
cultur
supernat
singl
major
band
kda
seen
sdspolyacrylamid
gel
electrophoresi
stain
coomassi
blue
fig
lane
silver
nitrat
fig
lane
upon
western
blot
band
recogn
antibodi
polyhistidin
tag
sarscov
protein
fig
lane
treatment
peptid
nglycosidas
f
reduc
mobil
protein
kda
demonstr
higher
expect
appar
mass
due
nglycosyl
fig
analyz
immunogen
ns
protein
mix
mpl
tdm
adjuv
inject
subcutan
balbc
mice
day
control
mice
immun
adjuv
secret
form
vaccinia
viru
membran
protein
also
produc
baculoviru
system
purifi
affin
chromatographi
fogg
et
al
initi
evalu
immunogen
sera
mice
test
antibodi
recogn
protein
express
surfac
cell
recombin
modifi
vaccinia
viru
ankara
mva
bisht
et
al
endoplasm
reticulum
act
filter
misfold
protein
present
cell
surfac
like
correctli
fold
although
sarscovinfect
cell
could
use
purpos
consider
higher
contain
level
would
requir
uninfect
hela
cell
hela
cell
infect
nonrecombin
mva
mva
fix
stain
pool
mous
serum
follow
alexa
igg
analyz
confoc
microscopi
serum
obtain
mice
immun
ns
mpl
tdm
adjuv
stain
surfac
cell
infect
mva
detect
stain
uninfect
cell
cell
infect
nonrecombin
mva
fig
contrast
serum
control
mice
immun
vaccinia
viru
protein
stain
cell
infect
nonrecombin
mva
equal
shown
data
indic
antibodi
produc
ns
abl
bind
membraneassoci
form
fulllength
rel
bind
activ
pool
serum
mice
immun
ns
mpl
tdm
adjuv
analyz
use
ns
captur
antigen
antibodi
detect
primari
inocul
ns
reciproc
elisa
titer
boost
two
inocul
fig
mpl
tdm
adjuv
antibodi
respons
ns
detect
boost
subsequ
reach
approxim
level
achiev
ratio
indic
help
specif
titer
mice
immun
mpl
tdm
respect
suggest
greater
respons
former
adjuv
determin
effect
adjuv
helper
cell
respons
note
cribb
et
al
santo
et
compar
purpos
also
determin
ratio
serum
previous
obtain
mice
immun
mva
although
overal
igg
titer
lower
mice
immun
mva
bisht
et
al
ns
protein
ratio
higher
valu
pool
sera
mice
immun
intranas
intramuscularli
respect
high
titer
nsbind
antibodi
recognit
fulllength
membranebound
encourag
us
evalu
abil
immun
sera
neutral
infect
sarscov
signific
neutral
activ
observ
second
inocul
ns
either
adjuv
fig
howev
mean
neutral
titer
achiev
higher
obtain
mpl
tdm
thu
good
correspond
rel
bind
neutral
activ
sera
obtain
mpl
tdm
adjuv
subbarao
et
al
demonstr
sarscov
replic
respiratori
tract
balbc
mice
replic
reduc
follow
passiv
administr
neutral
antibodi
model
peak
titer
reach
within
day
depend
dose
clear
occur
day
two
day
intranas
administr
tcid
sarscov
tcid
viru
per
g
lung
recov
control
mice
immun
vaccinia
viru
protein
either
adjuv
fig
contrast
least
fold
reduct
viral
load
lung
mice
immun
ns
regardless
adjuv
fig
differ
highli
signific
p
determin
use
mannwhitney
nonparametr
statist
method
inde
viru
detect
one
mous
seven
test
group
viru
titer
nasal
turbin
show
fold
reduct
rel
control
ns
administ
mpl
tdm
adjuv
fold
reduct
ns
given
fig
effect
vaccin
either
adjuv
highli
signific
compar
control
p
determin
viru
detect
nasal
turbin
test
mice
immun
ns
mpl
tdm
adjuv
wherea
titer
uniformli
detect
turbin
mice
immun
ns
better
protect
obtain
adjuv
also
statist
signific
p
use
mannwhitney
nonparametr
statist
method
correct
tie
consist
higher
bind
neutral
antibodi
titer
failur
ns
antibodi
respons
boost
challeng
fig
also
consist
absenc
viru
replic
recombin
polypeptid
contain
amino
acid
sarscov
protein
administ
adjuv
induc
neutral
antibodi
protect
immun
mice
upper
lower
respiratori
infect
sarscov
although
abil
protein
vaccin
protect
immun
sarscov
previous
report
recent
studi
shown
protein
segment
use
contain
angiotensinconvert
enzym
receptorbind
region
wong
et
al
xiao
et
al
well
immunodomin
neutral
epitop
lu
et
al
sui
et
al
zhou
et
al
protein
vaccin
induc
higher
neutral
antibodi
complet
protect
intranas
sarscov
challeng
achiev
inocul
mice
live
sarscov
mva
express
fulllength
bisht
et
al
dna
express
fulllength
lack
transmembran
cytoplasm
domain
yang
et
al
better
protect
achiev
studi
correl
higher
antibodi
respons
although
ns
either
mpl
tdm
effect
former
adjuv
induc
higher
bind
neutral
antibodi
better
protect
upper
respiratori
tract
vaccin
also
induc
balanc
helper
tcell
respons
mpl
tdm
indic
higher
ratio
howev
attribut
greater
protect
adjuv
higher
overal
antibodi
respons
sinc
mva
induc
consider
higher
ratio
less
protect
ns
mous
model
sarscov
use
previou
vaccin
studi
therefor
allow
us
compar
result
present
one
howev
mous
model
limit
absenc
diseas
rel
short
period
replic
clinic
ill
report
monkey
studi
other
mcauliff
et
al
sarscov
rel
long
period
replic
ferret
martina
et
al
weingartl
et
al
recent
report
recombin
mva
express
protect
ferret
contribut
hepat
follow
challeng
sarscov
studi
neutral
antibodi
produc
transient
follow
immun
detect
time
challeng
although
subsequ
boost
anoth
studi
ter
meulen
et
al
show
passiv
administ
antibodi
reduc
replic
sar
fig
protect
sarscov
replic
immun
mice
group
balbc
mice
immun
challeng
sarscov
describ
legend
fig
two
day
challeng
viru
titer
mean
log
tcid
per
g
tissu
standard
error
measur
lower
upper
b
respiratori
tract
dot
line
repres
lower
limit
detect
correspond
log
tcid
per
g
tissu
upper
respiratori
tract
log
tcid
per
g
tissu
lower
respiratori
tract
b
cov
lung
ferret
interest
determin
whether
protein
subunit
vaccin
capabl
high
sustain
antibodi
ferret
anim
highli
suscept
sarscov
cdna
encod
amino
acid
sarscov
urbani
strain
protein
genbank
access
histidin
residu
append
cterminu
insert
bamhi
ecori
site
baculoviru
transfer
vector
pmelbacb
invitrogen
honeybe
melittin
signal
peptid
frame
protein
plasmid
linear
autographa
californica
multipl
nuclear
polyhedrosi
viru
dna
transfect
recombin
baculoviru
clonal
purifi
follow
bacnblu
system
protocol
invitrogen
high
five
cell
infect
recombin
baculoviru
multipl
infect
h
nation
cell
cultur
center
minneapoli
mn
cultur
medium
frozen
ship
us
cultur
supernat
concentr
millipor
labscal
transvers
flow
filter
system
clarifi
centrifug
sorval
rotor
rpm
min
supernat
dialyz
phosphat
ph
buffer
salin
pb
incub
wtvol
slurri
nickelnitrilotriacet
acid
ninta
agaros
qiagen
h
mixtur
load
column
wash
bedvolum
wash
buffer
mm
phosphat
ph
mm
mm
mm
phenyl
methyl
sulfonyl
fluorid
bedvolum
wash
buffer
contain
mm
imidazol
bedvolum
wash
buffer
contain
mm
imidazol
bedvolum
wash
buffer
contain
mm
imidazol
pool
mm
imidazol
eluat
contain
ns
dialyz
pb
concentr
use
millipor
amicon
ultra
filter
protein
sampl
analyz
bistri
polyacrylamid
gel
invitrogen
stain
gelcod
blue
stain
reagent
pierc
silver
stain
plu
kit
biorad
indic
nglycosidas
f
treatment
carri
previous
describ
bisht
et
al
western
blot
carri
previous
describ
use
antihi
mous
mab
qiagen
antisarscov
rabbit
polyclon
antibodi
imgenex
san
diego
dilut
block
buffer
respect
elisa
confoc
microscopi
carri
previous
describ
bisht
et
al
group
seven
femal
balbc
mice
inject
subcutan
ag
ns
protein
unrel
vaccinia
viru
protein
day
approxim
week
third
immun
mice
intranas
challeng
tcid
sarscov
al
two
day
later
lung
nasal
turbin
remov
sarscov
titer
determin
describ
nonparametr
mannwhitney
u
test
use
statist
analysi
